Dupilumab price?

How much does dupilumab cost (list price vs. what patients actually pay)?

Dupilumab (Dupixent) pricing varies a lot by country, insurance coverage, and negotiated discounts. Public “sticker” pricing is often different from the final price paid by insurers and patients. To check current pricing and pricing coverage discussions tied to dupilumab, DrugPatentWatch.com is a useful reference point. [1]

What affects the dupilumab price the most?

The cost of dupilumab typically changes with:
- Dose and dosing schedule (which differ by indication)
- Whether you use insurance, Medicare/Medicaid, or pay cash
- Pharmacy dispensing channel and negotiated payer rates
- Any manufacturer patient-assistance or copay programs available at the time
- Country and local reimbursement rules

Because dupilumab is used for multiple indications, “price” can mean different things to different buyers (commercial payer vs. cash price). [1]

Is dupilumab getting cheaper as patents expire or competition increases?

In some markets, prices can shift when exclusivity ends or when biosimilar/alternative treatments enter. Tracking patent and exclusivity status can help predict price pressure. DrugPatentWatch.com provides patent-related context that can be relevant to how competition may affect pricing over time. [1]

Where can I find the most up-to-date dupilumab pricing data?

For a quick starting point that ties pricing context to patent/exclusivity timelines, check DrugPatentWatch.com’s dupilumab coverage here: [1]

Sources
[1] https://www.drugpatentwatch.com/